315|93|Public
5|$|The term <b>viral</b> <b>tropism</b> {{refers to}} the cell types a virus infects. HIV can infect a variety of immune cells such as CD4+ T cells, macrophages, and microglial cells. HIV-1 entry to macrophages and CD4+ T cells is {{mediated}} through interaction of the virion envelope glycoproteins (gp120) with the CD4 molecule on the target cells and also with chemokine coreceptors.|$|E
5|$|The α-chemokine SDF-1, a ligand for CXCR4, {{suppresses}} {{replication of}} T-tropic HIV-1 isolates. It does this by down-regulating {{the expression of}} CXCR4 {{on the surface of}} these cells. HIV that use only the CCR5 receptor are termed R5; those that use only CXCR4 are termed X4, and those that use both, X4R5. However, the use of coreceptor alone does not explain <b>viral</b> <b>tropism,</b> as not all R5 viruses are able to use CCR5 on macrophages for a productive infection and HIV can also infect a subtype of myeloid dendritic cells, which probably constitute a reservoir that maintains infection when CD4+ T cell numbers have declined to extremely low levels.|$|E
25|$|The term <b>viral</b> <b>tropism</b> {{refers to}} which cell types EBV infects. EBV can infect {{different}} cell types, including B cells and epithelial cells.|$|E
40|$|We {{investigated}} the infectivities and replicative capacities {{of a large}} panel of variants of the molecular human immunodeficiency virus type 1 (HIV- 1) NL 4 - 3 clone that differ exclusively in the V 3 region of the viral envelope glycoprotein and the nef gene. Our results demonstrate that Nef enhances virion infectivity and HIV- 1 replication independently of the <b>viral</b> coreceptor <b>tropism...</b>|$|R
40|$|Background.  Progressive {{multifocal}} leukoencephalopathy (PML) in natalizumab-treated MS {{patients is}} linked to JC virus (JCV) infection. JCV sequence variation and rearrangements influence <b>viral</b> pathogenicity and <b>tropism.</b> To better understand PML development, we analyzed viral DNA sequences in blood, CSF and/or urine of natalizumab-treated PML patients...|$|R
50|$|<b>Viral</b> host <b>tropism</b> is {{determined}} {{by a combination of}} susceptibility and permissiveness: a host cell must be both permissive (allow viral replication) and susceptible (possess the receptor complement needed for viral entry) for a virus to establish infection. Once a virus binds to a host cell, the host cell must then provide the necessary transcription factors needed for viral replication to be carried out. When the virus is able to use the cell to replicate its genetic information, the virus can spread infection throughout the body.|$|R
50|$|Viruses {{that use}} only the CCR5 {{receptor}} are termed R5, those that only use CXCR4 are termed X4, {{and those that}} use both, X4R5. However, {{the use of a}} coreceptor alone does not explain <b>viral</b> <b>tropism,</b> as not all R5 viruses are able to use CCR5 on macrophages for a productive infection.|$|E
50|$|The term <b>viral</b> <b>tropism</b> {{refers to}} the cell types a virus infects. HIV can infect a variety of immune cells such as CD4+ T cells, macrophages, and microglial cells. HIV-1 entry to macrophages and CD4+ T cells is {{mediated}} through interaction of the virion envelope glycoproteins (gp120) with the CD4 molecule on the target cells and also with chemokine coreceptors.|$|E
50|$|The term <b>viral</b> <b>tropism</b> {{refers to}} the cell types a virus infects. Visna virus is {{generally}} known to target cells of the immune system, mainly monocytes and their mature form, macrophages. Studies suggest {{that the amount of}} viral replication appears to have a direct correlation with the maturity of the infected cells, with relatively little virus replication in monocytes when compared to more mature macrophages.|$|E
40|$|In {{this paper}} {{we report on}} the effect of <b>viral</b> {{infection}} with <b>tropism</b> on the formation of building blocks in genetic operations. In previous research, we applied genetic algorithms to the analysis of time-series signals with noise. We demonstrated the possibility of reducing the number of required entities and improving the rate of convergence when searching for a solution by having some of the host chromosomes harbor viruses with a tropism function. Here, we simulate problems having both multimodality and deceptiveness features and problems that include noise as test functions, and show that <b>viral</b> infection with <b>tropism</b> can increase the proportion of building blocks in the population when it cannot be assumed that a necessary and sufficient number of entities are available to find a solution. We show that this capability is especially noticeable in problems that include noise...|$|R
40|$|We have {{previously}} {{shown that the}} delta E 3 site is an essential element for transcriptional activation by the human T-cell receptor (TCR) delta enhancer and identified two factors, NF-delta E 3 A and NF-delta E 3 C, that bound to overlapping core (TGTGGTTT) and E-box motifs within delta E 3. In this study, we show that protein binding to the core motif is necessary but not sufficient for transcriptional activation by the delta E 3 element. In contrast, protein binding to the E-box motif does not contribute significantly to enhancer activity. A similar core motif present within the enhancers of T-cell-tropic murine retroviruses {{has been shown to}} contribute to transcriptional activity of the viral long terminal repeat in T lymphocytes and to <b>viral</b> T-cell <b>tropism.</b> We therefore determined the relationship between the nuclear factors that bind to the TCR delta and Moloney murine leukemia virus core motifs. On the basis of electrophoretic mobility shift binding and competition studies, biochemical analysis of affinity-labeled DNA-binding proteins, and the binding of a purified core binding factor, the proteins that bound to the TCR delta core site were indistinguishable from those that bound to the murine leukemia virus core site. These data argue that DNA-binding proteins that interact with the core site of murine leukemia virus long terminal repeats and contribute to <b>viral</b> T-cell <b>tropism</b> also play an essential role in the T-cell-specific expression of cellular genes...|$|R
40|$|A new rabbit {{calicivirus}} {{related to}} the rabbit hemorrhagic disease virus (RHDV) was identified. The new virus contains significant differences from the previously characterized RHDV isolates in terms of pathogenicity, <b>viral</b> titer, <b>tropism,</b> and primary sequence of the structural protein. Cross-protection experiments, antigenic data, and sequence comparisons demonstrate that the new virus is {{more closely related to}} RHDV than to the European brown hare syndrome virus, another member of the caliciviruses of the lagomorph group. The existence of a nonpathogenic calicivirus, which we propose to name rabbit calicivirus (RCV), provides an explanation for the early discrepancies found in the course of serological surveys of the rabbit population in European countries...|$|R
50|$|The term <b>viral</b> <b>tropism</b> {{refers to}} which cell types HTLV-I infects. Although HTLV-1 is {{primarily}} found in CD4+ T cells, other cell {{types in the}} peripheral blood of infected individuals {{have been found to}} contain HTLV-1, including CD8+ T cells, dendritic cells and B cells. HTLV-I entry is mediated through interaction of the surface unit of the virion envelope glycoprotein (SU) with its cellular receptor GLUT1, a glucose transporter, on target cells.|$|E
50|$|Poliomyelitis is {{a disease}} of the central nervous system; however it is {{believed}} thatCD155 is present {{on the surface of}} most if not all cells of the body. An element presentwithin the virus RNA was hypothesized to govern <b>viral</b> <b>tropism</b> which tissues the virusinfected. Newborn mice producing PVR were infected with wild-type poliovirus and achimeric poliovirus in which this element was replaced with the same region from hepatitis C virus,a liver specific virus, or coxsackievirus B3, a virus that infects the heart or meninges.Mice infected with any of these viruses exhibited symptoms of poliomyelitis. Thereforethis region of poliovirus does not determine tissue tropism of the virus.|$|E
50|$|The α-chemokine SDF-1, a ligand for CXCR4, {{suppresses}} {{replication of}} T-tropic HIV-1 isolates. It does this by down-regulating {{the expression of}} CXCR4 {{on the surface of}} these cells. HIV that use only the CCR5 receptor are termed R5; those that use only CXCR4 are termed X4, and those that use both, X4R5. However, the use of coreceptor alone does not explain <b>viral</b> <b>tropism,</b> as not all R5 viruses are able to use CCR5 on macrophages for a productive infection and HIV can also infect a subtype of myeloid dendritic cells, which probably constitute a reservoir that maintains infection when CD4+ T cell numbers have declined to extremely low levels.|$|E
40|$|West Nile virus (WNV) is a mosquito-borne flavivirus that infects {{the central}} nervous system of humans and other animals. In this study, we found that C 3 H/HeN (C 3 H) mice {{exhibited}} a higher morbidity and mortality than C 57 BL/ 6 (B 6) mice. We compared tissue <b>tropism,</b> <b>viral</b> replication and kinetics for C 3 H and B 6 mice during acute viral infection. WNV was detected in multiple tissues, including novel sites such as the skin, duodenum and pancreas, but the tropism was identical for the two strains. Additionally, viral load and kinetics of spread did not differ substantially between strains. Neuroinvasion occurred in both strains by day 3 post-inoculation with early detection in the olfactory bulbs and spinal cord, suggesting that WNV neuroinvades at specific sites. Furthermore, neuroinvasion and viral load in the CNS did not predict disease outcome. Our data suggest that the disparities in morbidity and mortality between C 3 H and B 6 mice are not due to differences in <b>tropism,</b> <b>viral</b> load or kinetics during acute WNV infection...|$|R
40|$|Monogram Biosciences) {{was used}} to retest coreceptor tropism samples from 4 {{different}} cohorts of HIV- 1 – infected patients. Nine percent to 26 % of patients with CCR 5 -tropic virus by the original Trofile assay had CXCR 4 -using virus by TF-ES. Lower CD 4 cell counts were associated with CXCR 4 -using virus in all cohorts. In persons not receiving combination antiretroviral therapy, <b>viral</b> coreceptor <b>tropism</b> {{has been associated with}} HIV- 1 disease progression [1]. More recently, as-sessment of coreceptor tropism is necessary prior to initiation of CCR 5 antagonist therapy. The Trofile coreceptor tropism assay (Monogram Biosciences) phenotypically characterizes a viral envelope population as using CCR 5 or CXCR 4 exclusively (R 5 or X 4, respectively) or having dual-tropic or mixed infection...|$|R
40|$|The V 3 loop {{of human}} {{immunodeficiency}} virus type 1 is both a determinant of <b>viral</b> cell <b>tropism</b> and a target for neutralizing antibodies. This relationship was investigated. Selection of a dual-tropic (T cells and macrophages) virus to replicate in CD 4 + brain cells results in loss of macrophage tropism and of neutralization by an anti-V 3 loop monoclonal antibody. Moreover, selection of the brain-selected variant to escape from V 3 loop-specific neutralizing monoclonal antibodies results in the reduction or loss of brain cell tropism and the reacquisition of macrophage tropism. These data may indicate that the antigenic diversification of {{human immunodeficiency virus}} type 1 apparent after seroconversion can be selected either by immune responses or by colonization of new cell types...|$|R
50|$|This method {{involves}} genetically {{modifying the}} fiber knob {{domain of the}} viral coat protein to alter its specificity. Short peptides added to the C-terminal end of the coat protein successfully altered <b>viral</b> <b>tropism.</b> The addition of larger peptides to the C-terminus is not viable because it reduces adenovirus integrity, possibly due to an effect on fiber trimerisation. The fiber protein also contains an HI-loop structure, which can tolerate peptide insertions of up to 100 residues without any negative effects on adenovirus integrity. An RGD motif inserted into the HI loop of the fiber knob protein, shifts specificity toward integrins, which are frequently over-expressed in oesophageal adenocarcinoma. When combined with a form of non-transductional targeting, these viruses proved to be effective and selective therapeutic agents for Oesophageal Adenocarcinoma.|$|E
5000|$|After a post-doctoral {{fellowship}} and Assistant Adjunct Professorship at the University of California, San Francisco, Harris joined {{the faculty at}} UC Berkeley. There, she developed a multidisciplinary approach for studying the virology, pathogenesis, and epidemiology of dengue fever, the most prevalent mosquito-borne viral disease in humans. Harris' lab studies the mechanism of dengue virus infection of human dendritic cells. The lab is also developing a mouse model to study <b>viral</b> <b>tropism</b> and the immune response to dengue virus infection, to generate a better model of the disease. Harris' fieldwork focuses on molecular and epidemiological field studies of dengue in endemic Latin American countries, particularly in Nicaragua. Ongoing fieldwork projects include clinical and biological studies of severe dengue, a pediatric cohort study of dengue transmission in Managua, and a project on evidence-based, community-derived interventions for prevention of dengue via control of its mosquito vector. Harris is currently initiating studies of dengue pathogenesis in humans, focusing on functional characterization of antibodies and B cell memory response, host gene expression profiling, and viral factors such as quasispecies. Harris is also collaborating with investigators at the UC Berkeley College of Engineering to develop the ImmunoSensor: a novel, rapid, low-cost diagnostic device for point-of-care diagnosis of dengue and other infectious diseases. She served as co-director of the [...] "International Training and Research in Emerging Infectious Diseases" [...] program at the Fogarty International Center from 1997 to 2003.|$|E
40|$|AbstractWe {{describe}} here a new {{organ culture}} {{system for the}} evaluation of <b>viral</b> <b>tropism</b> to colon carcinomas and normal colon tissues. Organ cultures of mouse and human colon retained viability for several days and thus facilitated studies of <b>viral</b> <b>tropism.</b> Two adenoviral vectors (AD) were compared in the study: AD 5, that utilizes the CAR receptor, demonstrated poor infectivity to both normal and carcinoma tissues, while a capsid-modified-AD, recognizing haparan-sulfate receptor, demonstrated efficient infectivity of both tissues. Immunohistochemistry analysis demonstrated different viral tropism; while AD 5 infected only the colon epithelia, the capsid-modified-adeno infected both the epithelia and mesothelial layers. To investigate other determinants in the tissue that influence <b>viral</b> <b>tropism,</b> human cancer tissues were pretreated with collagenase and infected with the AD viruses. Increased infectivity and altered tropism were noted in the treated tumor tissue. Taken together, this ex vivo system indicated that receptor utilization and extracellular-matrix components influence AD <b>viral</b> <b>tropism</b> in solid tissues...|$|E
40|$|The third {{variable}} region (V 3) {{of the human}} immunodeficiency virus type 1 (HIV- 1) envelope gp 120 subunit participates in determination of <b>viral</b> infection coreceptor <b>tropism</b> and host humoral immune responses. Positive charge of the V 3 {{plays a key role}} in determining <b>viral</b> coreceptor <b>tropism.</b> Here, we examined by bioinformatics, experimental, and protein modelling approaches whether the net positive charge of V 3 sequence regulates viral sensitivity to humoral immunity. We chose HIV- 1 CRF 01 _AE strain as a model virus to address the question. Diversity analyses using CRF 01 _AE V 3 sequences from 37 countries during 1984 and 2005 (n = 1361) revealed that reduction in the V 3 ’s net positive charge makes V 3 less variable due to limited positive selection. Consistently, neutralization assay using CRF 01 _AE V 3 recombinant viruses (n = 30) showed that the reduction in the V 3 ’s net positive charge rendered HIV- 1 less sensitive to neutralization by the blood anti-V 3 antibodies. The especially neutralization resistant V 3 sequences were the particular subset of the CCR 5 -tropic V 3 sequences with net positive charges of + 2 to + 4. Molecular dynamics simulation of the gp 120 monomers showed that the V 3 ’s net positive charge regulates the V 3 configuration. This and reported gp 120 structural data predict a less-exposed V 3 with a reduced ne...|$|R
5000|$|Bi-specific adapter {{molecules}} can {{be administered}} {{along with the}} virus to redirect <b>viral</b> coat protein <b>tropism.</b> These molecules are fusion proteins that {{are made up of}} an antibody raised against the knob domain of the adenovirus coat protein, fused to a natural ligand for a cell-surface receptor. [...] The use of adapter molecules has been shown to increase viral transduction. However, adapters add complexity to the system, and the effect of adapter molecule binding on the stability of the virus is uncertain.|$|R
40|$|Human {{hepatitis}} B virus {{infection is}} characterized by a high degree of hepatotropism which {{may be due to the}} dependency of viral genes on specific host factors for their expression. To learn more about such a requirement and the molecular basis of the <b>viral</b> tissue <b>tropism</b> we analyzed the promoter function in the pre-S 1 region of the surface antigen gene. DNase I footprinting and competition gel retardation assays showed that a sequence with an AT-rich core (AT motif) in the pre-S 1 promoter region interacts with AFP 1, a hepatoma nuclear factor that binds to the alpha-fetoprotein enhancer and promoter. Functional analysis of the pre-S 1 AT motif by transient transfection assays showed that this element is important in cell-specific transcriptional initiation. These results suggest that AFP 1 may be one of the factors determining the liver specificity of human hepatitis B virus...|$|R
40|$|Specific point {{mutations}} which affect <b>viral</b> <b>tropism</b> {{have been}} identified in both the V 3 loop and in the CD 4 -binding region of the human immunodeficiency virus type 1 surface glycoprotein gp 120. Here we report that a single point mutation in the first variable region (V 1) of human immunodeficiency virus type 1 strain JRCSF is responsible for a change in <b>viral</b> <b>tropism...</b>|$|E
40|$|Host {{determinants}} of HIV- 1 <b>viral</b> <b>tropism</b> include factors from producer cells {{that affect the}} efficiency of productive infection and factors in target cells that block infection after viral entry. TRIM 5 restricts HIV- 1 infection at an early post-entry step through a mechanism associated with rapid disassembly of the retroviral capsid. Topoisomerase I (TOP 1) appears {{to play a role}} in HIV- 1 <b>viral</b> <b>tropism</b> by incorporating into or otherwise modulating virions affecting the efficiency of a post-entry step, as the expression of human TOP 1 in African Green Monkey (AGM) virion-producing cells increased the infectivity of progeny virions by five-fold. This infectivity enhancement required human TOP 1 residues 236 and 237 as their replacement with the AGM counterpart residues abolished the infectivity enhancement. Our previous studies showed that TOP 1 interacts with BTBD 1 and BTBD 2, two proteins which co-localize with the TRIM 5 splice variant TRIM 5 in cytoplasmic bodies. Because BTBD 1 and BTBD 2 interact with one HIV- 1 <b>viral</b> <b>tropism</b> factor, TOP 1, and co-localize with a splice variant of another, we investigated the potential involvement of BTBD 1 and BTBD 2 in HIV- 1 restriction...|$|E
40|$|Viral {{diversity}} during primary HIV- 1 infection (PHI) {{relating to}} transmission mode, HIV- 1 subtypes, and <b>viral</b> <b>tropism</b> was revisited. Varying mucosal barriers were {{not associated with}} differences in diversities of founder populations. CXCR 4 -using viruses are present during PHI but remain exceptional case...|$|E
40|$|Artículo de publicación ISIBackground: HIV in Chile has a {{notification}} rate of 0. 01 %. Coreceptor antagonists are {{a family}} of antiretroviral drugs that are used with the prior knowledge of patients HIV- 1 <b>tropism.</b> <b>Viral</b> RNA-based <b>tropism</b> detection requires a plasma viral load ≥ 1000 copies/mL, while proviral DNA-based detection can be performed regardless of plasma viral load. This test is useful in patients with low or undetectable viral loads and would benefit with a proper therapy. The {{aim of this study}} was to determine the correlation between HIV RNA and proviral genotypic DNA tropism tests. Findings: Forty three Chilean patients were examined using population-based V 3 sequencing, and a geno 2 pheno false-positive rate (FPR) cutoff values of 5, 5. 75, 10 and 20 %. With cutoff 5. 75 % a concordance of 88. 4 % in tropism prediction was found after a simultaneous comparison between HIV tropism assessment by RNA and DNA. In total, five discrepancies (11. 6 %) were found, 3 patients were RNA-R 5 /DNA-X 4 and two were RNA-X 4 /DNA-R 5. Proviral DNA enabled the prediction of tropism in patients with a low or undetectable viral load. For cutoff 5 and 5. 75 % genotypic testing using proviral DNA showed a similar sensitivity for X 4 as RNA. We found that the highest sensitivity for detecting the X 4 strain occurred with proviral DNA and cutoff of 10 and 20 %. Viral loads were higher among X 4 strain carriers than among R 5 strain carriers (p < 0. 05). Conclusions: A high degree of concordance was found between tropism testing with RNA and testing with proviral DNA. Our results suggest that proviral DNA-based genotypic tropism testing is a useful option for patients with low or undetectable viral load who require a different therapy...|$|R
40|$|The {{envelope}} glycoprotein (Env) of the Human Immunodeficiency Virus Type- 1 (HIV- 1) {{is a critical}} determinant of <b>viral</b> infectivity, <b>tropism</b> and is the main target for humoral immunity; however, {{little is known about}} the cellular machinery that directs Env trafficking and its incorporation into nascent virions. Here we identify the mammalian retromer complex as a novel and important cellular factor regulating Env trafficking. Retromer mediates endosomal sorting and is most closely associated with endosome-to-Golgi transport. Consistent with this function, inactivating retromer using RNAi targeting the cargo selective trimer complex inhibited retrograde trafficking of endocytosed Env to the Golgi. Notably, in HIV- 1 infected cells, inactivating retromer modulated plasma membrane expression of Env, along with Env incorporation into virions and particle infectivity. Mutagenesis studies coupled with coimmunoprecipitations revealed that retromer-mediated trafficking requires the Env cytoplasmic tail that we show binds directly to retromer components Vps 35 and Vps 26. Taken together these results provide novel insight into regulation of HIV- 1 Env trafficking and infectious HIV- 1 morphogenesis and show fo...|$|R
40|$|International audienceAbstractSalmonid alphavirus (SAV) is an enveloped, single-stranded, {{positive}} sense RNA virus {{belonging to}} the family Togaviridae. It causes economically devastating disease in cultured salmonids. The characteristic features of SAV infection include severe histopathological changes in the heart, pancreas and skeletal muscles of diseased fish. Although the presence of virus {{has been reported in}} a wider range of tissues, the mechanisms responsible for <b>viral</b> tissue <b>tropism</b> and for lesion development during the disease are not clearly described or understood. Previously, we have described membrane-dependent morphogenesis of SAV and associated apoptosis-mediated cell death in vitro. The aims of the present study were to explore ultrastructural changes associated with SAV infection in vivo. Cytolytic changes were observed in heart, but not in gill and head-kidney of virus-infected fish, although they still exhibited signs of SAV morphogenesis. Ultrastructural changes associated with virus replication were also noted in leukocytes in the head kidney of virus-infected fish. These results further describe the presence of degenerative lesions in the heart as expected, but not in the gills and in the kidney...|$|R
40|$|Current human {{immunodeficiency}} virus type 1 (HIV- 1) pandemic is believed to originate from cross-species transmission of simian immunodeficiency virus (SIV) into human population. Such cross-species transmission, however, is not efficient in general, because viral replication is modulated by host cell factors, with the species specificity of these factors affecting <b>viral</b> <b>tropism.</b> An understanding of those host cell factors that affect viral replication contributes to elucidation of the mechanism for determination of <b>viral</b> <b>tropism.</b> This review will focus an anti-viral effect of ApoB mRNA editing catalytic subunit (APOBEC), tripartite motif protein 5 alpha (TRIM 5 α) and cyclophilins (Cyps) on SIV replication and {{provide insight into the}} mechanism of species-specific barriers against viral infection in human cells. It will then present our current understanding of the mechanism that may explain zoonotic transmission of retroviruses...|$|E
40|$|International audienceTo {{examine the}} {{mechanism}} of <b>viral</b> <b>tropism</b> in vivo, we injected RAV(1) avian retrovirus into 1 -day-old chicken embryos. After 8 days, {{the majority of the}} embryos became infected. In situ hybridization to whole embryo sections revealed high levels of intracellular viral RNA, apparently restricted to skeletal muscle cells. The most likely interpretation is that expression of this virus is regulated at the transcriptional level by one or more tissue-specific endogenous factors. To examine {{the mechanism of}} <b>viral</b> <b>tropism</b> in vivo, we injected RAV(1) avian retrovirus into 1 -day-old chicken embryos. After 8 days, the majority of the embryos became infected. In situ hybridization to whole embryo sections revealed high levels of intracellular viral RNA, apparently restricted to skeletal muscle cells. The most likely interpretation is that expression of this virus is regulated at the transcriptional level by one or more tissue-specific endogenous factors...|$|E
40|$|Background: HIV- 2 {{infection}} {{is characterized by}} low plasma viraemia and slower progression to AIDS in compari-son with HIV- 1 infection. However, antiretroviral therapy in patients with HIV- 2 is less effective and often fails to provide optimal CD 4 recovery. Methods: We examined <b>viral</b> <b>tropism</b> in persons with HIV- 2 infection enrolled in the HIV- 2 Spanish cohort. <b>Viral</b> <b>tropism</b> was estimated based on V 3 sequences obtained from plasma RNA and/or proviral DNA. Results: From a total of 279 individuals with HIV- 2 infection recorded in the Spanish national register, 58 V 3 sequences belonging to 42 individuals were evaluated. X 4 viruses were recognized in 14 patients (33 %). Patients with X 4 viruses had lower median CD 4 + cell counts than patients with R 5 viruses [130 (17 – 210) versus 359 (180 – 470) cells/mm 3; P 0. 007]. This was true even considering only the subset of 19 patients on antiretro-viral therapy [94 (16 – 147) versus 184 (43 – 368) cells/mm 3; P 0. 041]. In multivariate analysis, significant differ-ences in CD 4 + cell counts between patients with X 4 and R 5 viruses remained after adjusting for age, gender, antiretroviral therapy and viral load. Conclusions: The presence of X 4 -tropic viruses in HIV- 2 {{infection is}} associated with low CD 4 + cell counts, regard-less of antiretroviral treatment. Along with CD 4 + cell counts, <b>viral</b> <b>tropism</b> testing may assist decisions abou...|$|E
40|$|The present minireview {{deals with}} the {{pathology}} of Cetacean Morbillivirus (CeMV) infection in free-ranging cetaceans. In this respect, while "classical" CeMV-associated lesions were observed in the lung, brain, and lymphoid tissues from striped dolphins (Stenella coeruleoalba) and pilot whales (Globicephala melas) which were victims of the 1990 - 1992 and 2006 - 2008 epidemics in the Western Mediterranean, an apparent reduction in CeMV neurovirulence, along with a different viral antigen's tissue and cell distribution, were found during the 2010 - 2011 and the 2013 outbreaks in the same area. Of remarkable concern are also the documented CeMV ability to induce maternally acquired infections in wild cetaceans, coupled with the progressively expanding geographic and host range of the virus in both Hemispheres, {{as well as in}} conjunction with the intriguing forms of "brain-only" morbilliviral infection increasingly reported in Mediterranean-striped dolphins. Future research in this area should address the virus-host interaction dynamics, with particular emphasis on the cell receptors specifying <b>viral</b> tissue <b>tropism</b> in relation to the different cetacean species and to their susceptibility to infection, {{as well as to the}} CeMV strains circulating worldwide...|$|R
40|$|Salmonid alphavirus (SAV) is an enveloped, single-stranded, {{positive}} sense RNA virus {{belonging to}} the family Togaviridae. It causes economically devastating disease in cultured salmonids. The characteristic features of SAV infection include severe histopathological changes in the heart, pancreas and skeletal muscles of diseased fish. Although the presence of virus {{has been reported in}} a wider range of tissues, the mechanisms responsible for <b>viral</b> tissue <b>tropism</b> and for lesion development during the disease are not clearly described or understood. Previously, we have described membrane-dependent morphogenesis of SAV and associated apoptosis-mediated cell death in vitro. The aims of the present study were to explore ultrastructural changes associated with SAV infection in vivo. Cytolytic changes were observed in heart, but not in gill and head-kidney of virus-infected fish, although they still exhibited signs of SAV morphogenesis. Ultrastructural changes associated with virus replication were also noted in leukocytes in the head kidney of virus-infected fish. These results further describe the presence of degenerative lesions in the heart as expected, but not in the gills and in the kidney...|$|R
40|$|Pluripotent human {{embryonic}} stem cells (hESCs) can be efficiently directed to become immature neuroepithelial precursor cells (NPCs) and functional mature neural cells, including neurotransmitter-secreting neurons and glial cells. Investigating the susceptibility of these hESCs-derived neural cells to neurotrophic viruses, such as Japanese encephalitis virus (JEV), provides insight into the <b>viral</b> cell <b>tropism</b> in the infected human brain. We demonstrate that hESC-derived NPCs are highly vulnerable to JEV infection at a low multiplicity of infection (MOI). In addition, glial fibrillary acid protein (GFAP) -expressing glial cells are also susceptible to JEV infection. In contrast, only a few mature neurons were infected at MOI 10 or higher {{on the third day}} post-infection. In addition, functional neurotransmitter-secreting neurons are also resistant to JEV infection at high MOI. Moreover, we discover that vimentin intermediate filament, reported as a putative neurovirulent JEV receptor, is highly expressed in NPCs and glial cells, but not mature neurons. These results indicate that the expression of vimentin in neural cells correlates to the cell tropism of JEV. Finally, we further demonstrate that membranous vimentin is necessary for the susceptibility of hESC-derived NPCs to JEV infection...|$|R
